These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25736544)

  • 21. Seasonal changes in calcium homeostasis affect the incidence of postoperative tetany in patients with Graves' disease.
    Yamashita H; Noguchi S; Murakami T; Watanabe S; Uchino S; Ohshima A; Kawamoto H; Toda M; Yamashita H
    Surgery; 2000 Apr; 127(4):377-82. PubMed ID: 10776427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methimazole discontinuation before radioiodine therapy in patients with Graves' disease.
    Zakavi SR; Khazaei G; Sadeghi R; Ayati N; Davachi B; Bonakdaran S; Jabbari Nooghabi M; Moosavi Z
    Nucl Med Commun; 2015 Dec; 36(12):1202-7. PubMed ID: 26426965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
    Kobe C; Weber I; Eschner W; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(4):153-6. PubMed ID: 18690374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of the Intestinal Microbial Flora and the Serum IL-17 Level in Patients with Graves' Disease Complicated with Vitamin D Deficiency.
    Yang M; Li F; Zhang R; Wu Y; Yang Q; Wang F; Yu Z; Liu J; Cha B; Gong Q; Yang B; Sun B; Ding H
    Int Arch Allergy Immunol; 2022; 183(2):225-234. PubMed ID: 34544076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.
    Park SE; Cho MA; Kim SH; Rhee Y; Kang ES; Ahn CW; Cha BS; Lee EJ; Kim KR; Lee HC; Lim SK
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):854-8. PubMed ID: 17437520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
    Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
    Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
    Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effect of radioactive iodine therapy on CXCL-10 production in Graves' disease.
    Dong QY; Li SJ; Gao GQ; Liu XM; Li WX; Liang CG; Du WH; Wsng YL
    Clin Invest Med; 2011 Oct; 34(5):E262. PubMed ID: 21968267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease.
    Santos RB; Romaldini JH; Ward LS
    Thyroid; 2004 Jul; 14(7):525-30. PubMed ID: 15307942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance and Prognostic Effect of Serum 25-hydroxyvitamin D Concentrations in Critical and Severe Hand, Foot and Mouth Disease.
    Dang HX; Liu CJ; Li J; Chen SJ; Xu F
    Nutrients; 2017 May; 9(5):. PubMed ID: 28489032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of postoperative hypocalcemia in vitamin D-deficient Graves' patients after total thyroidectomy.
    Erbil Y; Ozbey NC; Sari S; Unalp HR; Agcaoglu O; Ersöz F; Issever H; Ozarmagan S
    Am J Surg; 2011 May; 201(5):685-91. PubMed ID: 21545922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Vitamin D Status and its Impact on Thyroid Related Parameters in New Onset Graves' Disease- A Cross-sectional Observational Study.
    Mangaraj S; Choudhury AK; Swain BM; Sarangi PK; Mohanty BK; Baliarsinha AK
    Indian J Endocrinol Metab; 2019; 23(1):35-39. PubMed ID: 31016150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.